Capital World Investors Vertex Pharmaceuticals Inc Transaction History

Capital World Investors

  • $592 Billion
  • Q1 2025

A detailed history of Capital World Investors transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital World Investors holds 28,533,308 shares of VRTX stock, worth $12.4 Billion. This represents 2.34% of its overall portfolio holdings.

Number of Shares
28,533,308
Previous 28,325,695 0.73%
Holding current value
$12.4 Billion
Previous $11.4 Billion 21.27%
% of portfolio
2.34%
Previous 1.8%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$402.49 - $513.76 $83.6 Million - $107 Million
207,613 Added 0.73%
28,533,308 $13.8 Billion
Q4 2024

Feb 13, 2025
BUY
$396.64 - $516.74 $601 Million - $783 Million
1,514,993 Added 5.65%
28,325,695 $11.4 Billion
Q3 2024

Nov 13, 2024
BUY
$460.0 - $505.78 $47.3 Million - $52 Million
102,736 Added 0.38%
26,810,702 $12.5 Billion
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $448 Million - $554 Million
1,140,782 Added 4.46%
26,707,966 $12.5 Billion
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $1.53 Billion - $1.68 Billion
3,761,414 Added 17.25%
25,567,184 $10.7 Billion
Q4 2023

Feb 13, 2024
BUY
$343.0 - $410.68 $1.31 Billion - $1.57 Billion
3,824,103 Added 21.27%
21,805,770 $8.87 Billion
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $217 Million - $232 Million
641,033 Added 3.7%
17,981,667 $6.25 Billion
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $376 Million - $421 Million
1,196,211 Added 7.41%
17,340,634 $6.1 Billion
Q1 2023

May 15, 2023
BUY
$283.23 - $323.1 $956 Million - $1.09 Billion
3,375,417 Added 26.43%
16,144,423 $5.09 Billion
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $69.8 Million - $78.5 Million
244,327 Added 1.95%
12,769,006 $3.69 Billion
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $12.4 Million - $13.8 Million
-45,253 Reduced 0.36%
12,524,679 $3.63 Billion
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $22.6 Million - $28.1 Million
-96,198 Reduced 0.76%
12,569,932 $3.54 Billion
Q1 2022

May 16, 2022
BUY
$221.42 - $260.97 $254 Million - $299 Million
1,145,275 Added 9.94%
12,666,130 $3.31 Billion
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $84.7 Million - $107 Million
478,553 Added 4.33%
11,520,855 $2.53 Billion
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $4.88 Million - $5.47 Million
26,924 Added 0.24%
11,042,302 $2 Billion
Q2 2021

Aug 16, 2021
BUY
$187.49 - $221.1 $255 Million - $300 Million
1,357,903 Added 14.06%
11,015,378 $2.22 Billion
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $687,306 - $801,149
3,320 Added 0.03%
9,657,475 $2.08 Billion
Q4 2020

Feb 12, 2021
SELL
$207.01 - $276.09 $353 Million - $471 Million
-1,706,360 Reduced 15.02%
9,654,155 $2.28 Billion
Q3 2020

Nov 13, 2020
SELL
$255.65 - $303.1 $288 Million - $342 Million
-1,127,728 Reduced 9.03%
11,360,515 $3.09 Billion
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $20.6 Million - $27.1 Million
-91,475 Reduced 0.73%
12,488,243 $3.63 Billion
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $396 Million - $491 Million
1,981,607 Added 18.7%
12,579,718 $2.99 Billion
Q4 2019

Feb 18, 2020
BUY
$166.71 - $223.91 $1.88 Million - $2.53 Million
11,278 Added 0.11%
10,598,111 $2.32 Billion
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $143 Million - $161 Million
-862,721 Reduced 7.53%
10,586,833 $1.79 Billion
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $88.2 Million - $102 Million
535,827 Added 4.91%
11,449,554 $2.1 Billion
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $169 Million - $201 Million
1,033,361 Added 10.46%
10,913,727 $2.01 Billion
Q4 2018

Feb 14, 2019
BUY
$151.91 - $192.21 $331 Million - $419 Million
2,181,475 Added 28.33%
9,880,366 $1.64 Billion
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $552 Million - $635 Million
-3,293,143 Reduced 29.96%
7,698,891 $1.48 Billion
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $290 Million - $339 Million
1,993,107 Added 22.15%
10,992,034 $1.87 Billion
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $471 Million - $551 Million
3,109,444 Added 52.8%
8,998,927 $1.47 Billion
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $779 Million - $882 Million
-5,672,358 Reduced 49.06%
5,889,483 $883 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $1.71 Billion - $1.88 Billion
11,561,841
11,561,841 $1.76 Billion

Others Institutions Holding VRTX

# of Institutions
1,830
Shares Held
233M
Call Options Held
1.38M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $112B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email